Translational Science

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

We reveal The Medicine Maker 2021 Power List!

We find out the story behind the Baylor College of Medicine Center for Space Medicine.